DGAP-Adhoc: PAION AG TO ISSUE APPROX. 2.4 MILLION SHARES AT EUR 2.05 PER SHARE IN CAPITAL INCREASE WITH SUBSCRIPTION RIGHTS

2017. február 07., kedd, 08:51





DGAP-Ad-hoc: PAION AG / Key word(s): Capital Increase


PAION AG TO ISSUE APPROX. 2.4 MILLION SHARES AT EUR 2.05 PER SHARE IN CAPITAL INCREASE WITH SUBSCRIPTION RIGHTS


07-Feb-2017 / 08:51 CET/CEST


Disclosure of an inside information acc. to Article 17 MAR, transmitted by DGAP - a service of EQS Group AG.


The issuer is solely responsible for the content of this announcement.



NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE
UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR
RELEASE WOULD BE UNLAWFUL.

PAION AG TO ISSUE APPROX. 2.4 MILLION SHARES AT EUR 2.05 PER SHARE IN
CAPITAL INCREASE WITH SUBSCRIPTION RIGHTS

Aachen (Germany), 07 February 2017 - The Management Board of the specialty
pharmaceutical company PAION AG (ISIN DE000A0B65S3; Frankfurt Stock
Exchange, Prime Standard: PA8) has today decided with the approval of the
Supervisory Board of the same day, to increase the Company"s registered
share capital against contribution in cash from EUR 55,757,094.00 by EUR
2,439,023.00 to EUR 58,196,117.00 by issuing 2,439,023 new, registered, nopar
value shares with a notional value of EUR 1.00 (the "New Shares"), each
with full dividend entitlement as of the fiscal year beginning 01 January
2016 while granting subscription rights to existing shareholders.

The ODDO SEYDLER BANK AG, Frankfurt, has committed to offer the New Shares
for sale to the existing shareholders of the Company at a subscription
ratio of 23:1 (indirect subscription right). That is twenty-three old
shares entitle the shareholder to subscribe for one New Share. The
subscription price is EUR 2.05 per share. Shareholders may subscribe for
the New Shares during the subscription period in the rights offering, which
is expected to commence on 10 February 2017 at 00:00 midnight CET and end
on 27 February 2017 at 24:00 midnight CET. The subscription rights to the
New Shares (ISIN DE000A2AA4K2/ WKN A2A A4K) are expected to be traded
during the period from 10 February 2017 through 23 February 2017 on the
regulated market (XETRA Frankfurt and XETRA Frankfurt Specialist) under the
ticker symbol PA8B on the Frankfurt Stock Exchange.

Subject to certain terms and conditions, a US-American institutional
investor has committed vis-à-vis the Company and ODDO SEYDLER BANK AG to
acquire any New Shares not subscribed for by existing shareholders or other
investors in connection with the rights offering at the subscription price
(backstop commitment).

For further details on the capital increase with subscription rights,
please see the subscription offer provisionally planned to be published in
the electronic Federal Gazette on 08 February 2017 and on the website of
PAION AG (www.paion.com).

PAION will receive gross proceeds of about EUR 4.99 million for the capital
increase with subscription rights.

PAION intends to use the proceeds of the capital increase primarily to
prepare and submit an application for market approval of remimazolam in
Japan.

The transaction is being handled by ODDO SEYDLER BANK AG.

Disclaimer:

This release contains certain forward-looking statements concerning the
future business of PAION AG. These forward-looking statements contained
herein are based on the current expectations, estimates and projections of
PAION AG"s management as of the date of this release. They are subject to a
number of assumptions and involve known and unknown risks, uncertainties
and other factors. Should actual conditions differ from the Company"s
assumptions, actual results and actions may differ materially from any
future results and developments expressed or implied by such forwardlooking
statements. Considering the risks, uncertainties and other factors
involved, recipients should not rely unreasonably upon these forwardlooking
statements. PAION AG has no obligation to periodically update any
such forward-looking statements to reflect future events or developments.

This release does not constitute an offer of securities for sale or a
solicitation of an offer to purchase securities of PAION AG in the United
States or any other jurisdiction. Neither this announcement nor anything
contained herein shall form the basis of, or be relied upon in connection
with, any offer or commitment whatsoever in any jurisdiction. The
securities of PAION AG may not be offered or sold in the United States
absent registration or an exemption from registration under the U.S.
Securities Act of 1933, as amended (the "Securities Act"). The securities
of PAION AG have not been, and will not be, registered under the Securities
Act.

PAION Contact

Ralf Penner

Director Investor Relations / Public Relations
PAION AG

Martinstrasse 10-12

52062 Aachen - Germany

Phone: +49 241 4453-152

E-mail: r.penner@paion.com

www.paion.com









07-Feb-2017 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


























Language: English
Company: PAION AG

Martinstr. 10-12

52062 Aachen

Germany
Phone: +49 (0)241-4453-0
Fax: +49 (0)241-4453-100
E-mail: info@paion.com
Internet: www.paion.com
ISIN: DE000A0B65S3
WKN: A0B65S
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange





 
End of Announcement DGAP News Service



542219  07-Feb-2017 CET/CEST






img
Tilos a hír bármilyen adatbázisba történő mentése vagy annak továbbítása harmadik fél számára;kereskedelmi viszonylatban vagy kereskedelmi céllal csak a Deutsche Gesellschaft für Ad-hoc-Publizität mbh írásos engedélyével történhet.